Group 1 - The article discusses the trend of financial professionals, particularly fund managers, transitioning to different roles, such as company secretaries, amid fluctuating fund performance [2] - Jiang Ying has been appointed as the new company secretary of Luoxin Pharmaceutical, succeeding Han Fengsheng, who resigned [2] - Jiang Ying holds dual degrees in Science and Economics from Peking University, as well as a Master's in Management from Peking University and a Master's in Finance from the University of Hong Kong [2] Group 2 - Jiang Ying's previous performance as a fund manager at Guotai Fund was subpar, with all three funds she managed showing losses during her tenure [4] - The funds managed by Jiang Ying include Guotai Science and Technology Innovation Board Two-Year Fixed Opening, which had a return of -12.48%, Guotai Small and Medium Growth with -34.28%, and Guotai Golden Bull Innovative Growth with -7.01% [4] - Despite the losses, the rankings of Guotai Science and Technology Innovation Board Two-Year Fixed Opening and Guotai Golden Bull Innovative Growth were within the top 50% of their respective categories [3] Group 3 - Jiang Ying's predecessor, Han Fengsheng, saw a steady increase in annual salary from 424,100 yuan in 2022 to 845,700 yuan in 2024 [3] - The article raises questions about Jiang Ying's potential income after transitioning from the fund industry to a corporate role [3]